Search
for
Sort by
Research 931–960 of 1000+
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Abstracts
- An Overview of Alopecias
- The treatment of alopecia areata
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Upadacitinib for the treatment of alopecia areata – A case report
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Low Humidity Alters Epidermal Gene Expression in vivo
- Neuroimmunology of Stress: Skin Takes Center Stage
- Skin wound healing in humans and mice: Challenges in translational research
- Molecular mechanisms of androgenetic alopecia
- Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Probing the Effects of Stress Mediators on the Human Hair Follicle
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Drug-Induced Skin, Nail and Hair Disorders
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Antioxidants in dermatology
- Green tea: Health benefits
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- The role of nuclear hormone receptors in cutaneous wound repair
- Oestrogen functions in skin and skin appendages
- Hair Follicle: A Novel Source of Multipotent Stem Cells for Tissue Engineering and Regenerative Medicine
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature